PTCT

NASDAQ · Biotechnology

Ptc Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$65.26

-0.11 (-0.17%)

As of Sep 21, 8:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 81%

Hold 3 14%

Sell 1 5%

Price Target

Analyst Price Target +19.5% upside

Low Target $54.55

Average Target $77.98

High Target $125.35

Current Price $65.26

Current
$65.26

Target
$77.98

$54.55 $77.98 avg $125.35

Scenario Analysis

Bear Case

$54.55

-16.4%

Low target

Base Case

$77.98

+19.5%

Avg target

Bull Case

$125.35

+92.1%

High target

Risk/Reward

5.6x

Highly favorable

Price in Context

52-Week High

$90.87

-28.2% from high

52-Week Low

$57.74

+13.0% from low

50-Day SMA

$75.08

-13.1% vs SMA

200-Day SMA

$61.55

+6.0% vs SMA

RSI (14)

25.1

Oversold

Target vs 52W High

$77.98

-14.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.7%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.3%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.8%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-41.0%